Colgate-Palmolive Company (CL) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary presents a mix of positive and negative elements. Strong growth in emerging markets and strategic interventions in Asia Pacific and Latin America are offset by sluggish performance in China and North America, as well as significant cost inflation pressures. The Q&A highlighted concerns over cost inflation and the lack of detailed guidance in certain areas. These factors balance out to a neutral sentiment, with no clear catalyst for a strong stock price movement.
Key Financial Performance
Organic Sales Growth Accelerated from the fourth quarter, driven by improved volume performance, particularly in Asia Pacific. Excluding the impact of private label pet food exit, volume and pricing grew in all 4 categories and 4 of 5 divisions.
Sales Growth in Emerging Markets Led by emerging markets where strong global brands have higher market shares and scale advantages. Investments in these markets are accretive in terms of growth prospects.
Gross Profit, Operating Profit, Earnings Per Share, and Free Cash Flow All showed growth, supported by strong net and organic sales growth, despite significant increases in raw material and packaging costs.
Advertising Investments Increased spending through omnichannel demand generation model, driving higher ROI and keeping brands top of mind with consumers.
Strategic Growth and Productivity Program Savings Annualized savings target of $200 million to $300 million, with the majority of savings focused in 2027 and 2028. Savings will fund investments in capabilities for the 2030 strategy and drive consistent EPS growth.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Emerging Markets Growth: Sales growth was led by emerging markets, where the company has higher market shares and scale advantages. Investments are being made in these regions due to their growth prospects.
Cost Savings Program: Announced an update to the strategic growth and productivity program with annualized savings target of $200 million to $300 million, focusing on 2027 and 2028. This will fund investments for the 2030 strategy and drive EPS growth.
Operational Flexibility: Flexibility in P&L allows the company to deliver short-term results in a volatile environment while building for long-term strategy.
2030 Strategic Plan: The company is executing its 2030 strategic plan, focusing on innovation, data, analytics, digital, and AI to scale capabilities and drive market share improvement.
Organizational Restructuring: Changes to organizational structure aim to reduce complexity and build a more agile company for an omnichannel environment.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Raw Material and Packaging Costs: Significant increases in raw material and packaging costs have been noted, which could impact gross margins for the year.
Economic and Market Uncertainty: Uncertainty regarding oil prices, interest rates, and consumer responses could adversely affect the company's performance in 2026.
Cost Inflation: The company is operating in a period of significant cost inflation, which could challenge profit and EPS growth.
Organizational Complexity: Efforts to reduce organizational complexity are ongoing, but challenges in achieving agility in an omnichannel environment remain.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
2026 Outlook: The company is confident in its outlook for the remainder of 2026 despite significant increases in raw material and packaging costs. Guidance has been adjusted to reflect reduced expectations for gross margin for the year.
Emerging Markets Growth: Emerging markets are expected to be accretive in terms of growth prospects. The company is investing in these regions where it has higher market shares and scale advantages.
2030 Strategic Plan: The company is focused on delivering short-term results while building for long-term success. Investments in innovation, data, analytics, digital, and AI will continue to scale across the organization to drive market share improvement and category growth.
Strategic Growth and Productivity Program: An updated annualized savings target of $200 million to $300 million has been announced, with the majority of savings expected in 2027 and 2028. The program is expected to be completed by the end of 2028 and will fund investments for the 2030 strategy and consistent EPS growth.
Organizational Structure Changes: Changes to reduce complexity and build a more agile company are being implemented to thrive in an omnichannel environment.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What are the tangible payoffs from reallocating marketing spend to higher growth areas, and how sustainable is the volume strength in emerging markets?
A:Noel Wallace highlighted that the interventions in emerging markets, particularly in Asia Pacific, Latin America, Africa, Middle East, and Europe, have shown positive results. Sustained high levels of advertising investment and good revenue growth management (RGM) have contributed to volume growth. However, the category remains sluggish in China, and North America is still undergoing strategic interventions to improve performance.
Q:Can you provide more color on the cost inflation embedded in guidance and the assumptions on crude oil and potential offsets?
A:The guidance includes $300 million of additional raw materials costs, with oil assumed at $110 per barrel. The biggest cost impacts are from oil byproducts, resins, petrochemicals, fats, and oils, which are expected to rise by over 20% year-on-year. Logistics costs are also up nearly 10%. Offsets include RGM productivity and cost-saving initiatives.
Q:What are the key puts and takes on gross margin headwinds, and is there scope for incremental pricing?
A:Gross margins are pressured due to increased oil and commodity costs, with $300 million in additional costs factored into guidance. Incremental pricing may be taken, driven by premium innovation and price pack architectures. Productivity initiatives and RGM efforts are expected to offset some of the cost pressures.
Q:Can you elaborate on the growth in Asia Pacific, particularly in India and China?
A:Growth in Asia Pacific was strong, driven by India and China. Strategic interventions, such as accelerated innovation and improved omnichannel execution, have shown positive results. The Colgate business in China delivered mid-single-digit growth in a flat market, and other markets like the Philippines, Thailand, and Malaysia also performed well.
Q:What is the context of category growth and market share performance in Latin America?
A:Latin America showed strong volume growth, driven by Mexico and Brazil. Strategic capabilities like omni demand generation, AI usage, and RGM have contributed to success. Innovation across all price points, particularly in premium segments, is driving growth. The region is expected to continue its momentum.
Q:How competitive is the U.S. Oral Care business, and what are the plans for improvement?
A:The U.S. Oral Care business remains competitive, with some competitors increasing couponing efforts. Sequential improvement is expected as new innovations are rolled out. Investments in innovation and strategic interventions are aimed at improving market share and performance.
Q:Does the inflationary environment alter pricing plans, particularly in emerging markets?
A:Pricing will be taken where opportunities arise, with a focus on innovation-led pricing. The company is monitoring consumer behavior closely and aims to balance pricing with strong innovation to maintain value propositions across different price points.
Q:What led to the expansion of the SGPP program, and how will the additional savings be utilized?
A:The SGPP program was expanded due to strong execution and additional opportunities identified by teams. The program is expected to generate $200-$300 million in savings by 2028, which will be used for incremental investments and bottom-line contributions.
Q:How is the company managing brand spend in the current cost environment?
A:The company remains committed to disciplined brand spending, focusing on innovation and omni demand generation. Increased advertising investment is planned, particularly in key geographies, with a focus on ROI and digital advertising.
Q:How is the Hill's business performing, and what are the growth opportunities?
A:Hill's delivered solid growth, with U.S. sales up 5% and strong performance in Science Diet and Prescription Diet. The business is gaining share across channels and benefiting from innovation. While the dry dog category is soft, growth in wet, cat, and Small Paws segments is strong. The company is focused on value-added innovation and leveraging its science-based approach.
Q:What is the impact of inflation on the Hill's consumer, and how sustainable is the momentum?
A:Hill's competes in the super-premium market and focuses on value-added innovation, particularly in Prescription Diet. While inflation may impact consumers, the company aims to offset this with strong innovation and science-based products. The business is expected to sustain momentum through its differentiated offerings.
Q:Review of Unclear Management Responses
A:Management avoided providing detailed insights into India’s growth specifics, citing that official numbers had not been announced. Additionally, while discussing North America, responses on the exact level of improvement and market share recovery lacked specificity. Similarly, the impact of GST on India’s business was not elaborated upon.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Conference opening
Drew release
EVP Special
Executive Chief
Forward statement
Officer Chief
Officer EVP
Palmolive Conference
President Executive
President Investor
Projects thought
Relations Drew
Relations Today
Relations remark
Special Projects
Tables press
assumption press
basis view
conference Executive
definition press
filing website
item Executive
measure definition
outlook QA
release Chairman
release conference
release filing
remark Executive
result Tables
result outlook
risk uncertainty
statement Forward
statement risk
uncertainty basis
view assumption
CL Transcript
Colgate-Palmolive Company (CL) Q1 2026 Earnings Call Transcript
Unknown5-1
The earnings call summary presents a mix of positive and negative elements. Strong growth in emerging markets and strategic interventions in Asia Pacific and Latin America are offset by sluggish performance in China and North America, as well as significant cost inflation pressures. The Q&A highlighted concerns over cost inflation and the lack of detailed guidance in certain areas. These factors balance out to a neutral sentiment, with no clear catalyst for a strong stock price movement.
Colgate-Palmolive Company (CL) Presents at UBS Global Consumer and Retail Conference Transcript
Neutral3-11
Colgate-Palmolive Company (CL) Presents at Consumer Analyst Group of New York Conference 2026 Transcript
Neutral2-20
Colgate-Palmolive Company (CL) Q4 2025 Earnings Call Transcript
Positive1-30
The earnings call reveals strong financial performance, with growth in earnings per share and free cash flow, despite challenges. The Q&A highlights optimism in emerging markets, strategic investments in innovation, and a flexible approach to FX management. However, challenges in North America and unclear management responses on specific strategies temper the outlook slightly. Overall, strong performance and positive guidance, especially in emerging markets and Hill's, suggest a positive stock price movement.
CL Slides
CL Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
